Madison Vaccines logo — Developing innovative vaccines for prostate cancer patients...

Madison Vaccines

Developing innovative vaccines for prostate cancer patients and a test to determine their effectiveness.

Founded 2012 Venture round Total: $15.81M Biotechnology, Health Care +1

General Information

Company Name Madison Vaccines
Founded Year 2012
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Madison Vaccines. To contact Madison Vaccines, visit madisonvaccines.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Madison Vaccines

Madison Vaccines, founded in 2012, is a biotechnology startup dedicated to the development of innovative vaccines for prostate cancer patients. Their mission is underscored by their slogan, "Developing innovative vaccines for prostate cancer patients and a test to determine their effectiveness." The company is also working on a test to identify patients who will benefit from these vaccines. In January 2017, Madison Vaccines secured a significant $3.31M in a venture round investment, with key funding coming from Wisconsin Investment Partners and Venture Investors. The company's focus on addressing the unmet medical needs of prostate cancer patients showcases promise in the rapidly developing fields of biotechnology, healthcare, and medical devices.

Taxonomy: prostate cancer, vaccines, cancer treatment, medical innovation, precision medicine, oncology, vaccine development, medical testing, biopharmaceuticals, clinical trials, cancer research, innovation, precision oncology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $3.31M 2
Wisconsin Investment Partners, Venture Investors
01 Jan 2017
Venture Round $1.50M 1
Wisconsin Investment Partners
01 Jan 2016
Series A $3.00M 4
State of Wisconsin Investment Board, WARF +2
10 Mar 2015
Series A $8.00M 3
State of Wisconsin Investment Board, Venture Investors +1
13 Jan 2014

Madison Vaccines Alternatives & Competitors

View All Alternatives
Madison Vaccines vs

Dedicated to developing effective and novel targeted treatments for cancer.

Grant
12 employees
Biopharma, Biotechnology
Madison Vaccines vs

Overcoming Resistance In Cancer

Post-IPO Equity
119 employees
Biopharma, Biotechnology
Madison Vaccines vs

Pioneering innovative vaccines and immunotherapies for critical unmet medical needs using advanced a...

Post-IPO Equity
Biotechnology, Health Care

FAQ About Madison Vaccines

Developing innovative vaccines for prostate cancer patients and a test to determine their effectiveness.
Madison Vaccines was founded in 2012.
Madison Vaccines operates in Biotechnology, Health Care and Medical Devices. Its work centres on prostate cancer, vaccines, cancer treatment and medical innovation.
Madison Vaccines has completed 4 funding rounds, raising a total of $15.81M. The latest funding stage is Venture round.
Top alternatives and competitors to Madison Vaccines include Soricimed Biopharma Inc., ORIC Pharmaceuticals Inc., Genocea Biosciences, Day One Biopharmaceuticals, OncoDiag. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Madison Vaccines and Soricimed Biopharma Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Madison Vaccines, https://bouncewatch.com/company/madison-vaccines, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes